Raymond James cuts CareTrust REIT stock price target on yield outlook
Raymond James reduced its price target on CareTrust REIT (CTRE) to $41 from $42, citing a yield outlook, while maintaining an Outperform rating. The firm noted CTRE's expansion and growth prospects, with $2.9B in investments year-to-date and a 4% dividend yield. CTRE's Q3 2026 earnings missed estimates, but revenue exceeded forecasts, showing a 35.6% increase. The company has a market cap of $10B and 44% revenue growth over the last twelve months.
How this was made
The 30-second read
Why it matters
Analyst target reduction signals a bearish short-term outlook, yet the revenue beat may attract value-oriented investors.
Market read
The price target change and earnings data provide fresh actionable information for traders focused on REITs and dividend yields.
What to watch
Potential upside from upcoming senior housing projects and pipeline investments not fully reflected in the target.
Background
Raymond James' note follows CTRE's Q3 2026 earnings release, highlighting a mixed performance with EPS below estimates but revenue exceeding forecasts.
Ticker impact
Raymond James lowered CTRE's price target to $41 and reported Q3 earnings miss on EPS but revenue beat.
likely modest downside as the lower target is priced in, though revenue beat could cushion the move
Target cut is a fresh analyst action; earnings miss on EPS is negative, but strong revenue growth may limit sell pressure.
Market effects
The REIT sector may see heightened scrutiny on earnings quality versus dividend yields.
US REIT market could experience slight pullback as analysts reassess valuation multiples.
Limited; impact confined to US senior housing REIT niche.
Counterpoint
Despite the target cut, the strong revenue growth and dividend track record could support a buying opportunity.
Key entities
- analystRaymond James
Equity research firm that issued the price target revision.
- companyCareTrust REIT
Senior housing REIT whose stock is the subject of the analysis.
